Evidence map›Paper›PMID 37663388›Full record

ArticleAvicenna journal of phytomedicine

Cytotoxicity of curcumin against CD44

Reza Panahizadeh, Mohammad Amin Vatankhah, Farhad Jeddi, AmirAhmad Arabzadeh, Kazem Nejati-Koshki, Ramin Salimnejad, Nowruz Najafzadeh

Open access · greenAbstract read
In one paragraph

Article in Avicenna journal of phytomedicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Reza PanahizadehStudents Research Committee, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Mohammad Amin VatankhahStudents Research Committee, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Farhad JeddiDepartment of Medical Genetics and Pathology, Faculty of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
AmirAhmad ArabzadehDepartment of Surgery, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Kazem Nejati-KoshkiPharmaceutical Sciences Research Center, Ardabil University of Medical Science, Ardabil, Iran.
Ramin SalimnejadResearch laboratory for Embryology and Stem Cells, Department of Anatomical Sciences, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Nowruz NajafzadehResearch laboratory for Embryology and Stem Cells, Department of Anatomical Sciences, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Ardabil University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Cancer stem cells (CSCs) remaining in the tumor tissues after applying treatments may cause recurrence or metastasis of prostate cancer (PC). Curcumin has the promising potential to target CSCs. Here, we aim to evaluate the cytotoxic effects of curcumin on the expression of miR-383-5p and miR-708-5p and their target genes in CD44 Materials and Methods: We used MTT assay to determine the optimal cytotoxic dose of curcumin on CD44 Results: Curcumin significantly enhanced the apoptosis in both CD44 Conclusion: Our findings indicate that curcumin, by promoting the expression of tumor suppressors, miR-383-5p and miR-708-5p, and inhibiting their target genes, induced its cytotoxicity against CD44

Indexed as

Curcuminhsa-miR-383-5phsa-miR-708-5pMicroRNAsNatural productsProstate neoplasms

Identifiers

PMID37663388
PMCPMC10474917
OpenAlexW4386407553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.